You just read:

Jazz Pharmaceuticals Announces U.S. FDA Approval of Sunosi™ (solriamfetol) for Excessive Daytime Sleepiness Associated with Narcolepsy or Obstructive Sleep Apnea

News provided by

Jazz Pharmaceuticals

20 Mar, 2019, 23:25 GMT